Calithera Biosciences Inc

NASDAQ:CALA  
0.21
+0.01 (+5.43%)
Earnings Announcements

Calithera Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results And Recent Highlights

Published: 03/31/2022 20:57 GMT
Calithera Biosciences Inc (CALA) - Calithera Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights.
Expects Cash and Cash Equivalents to Meet Operating Plan Through Q2 of 2023.
Qtrly Net Loss per Share, Basic and Diluted $0.92.
Q4 Earnings per Share View $-0.24 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.75 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.